This dual-action approach enhances insulin sensitivity and further reduces appetite and fat storage, often leading to even more substantial weight loss than GLP-1-only therapies
Treatment stage What may be common What deserves attention Week 1 Nausea, fullness, reduced appetite, bloating, indigestion, diarrhea, constipation, fatigue Repeated vomiting, severe pain, inability to stay hydrated Weeks 2 to 4 Early symptoms may settle, persist, or fluctuate Symptoms interfering with eating, drinking, or daily function Weeks 5 to 8 Symptoms may reappear after clinician-directed dose escalation A significant return or worsening of gastrointestinal symptoms Months 2 to 3 Some patients tolerate treatment more comfortably
Jensterle M, Rizzo M, Haluzk M, Jane A (2022) Efficacy of GLP-1 RA approved for weight management in patients with or without diabetes: a narrative review
Begin a targeted micronutrient regimen when you start your GLP-1 medication, or ideally even before
e39799, Sep
PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies at $189/mo month-to-month, or from $149/mo on the 6-month plan, making this powerful GLP-1 therapy accessible without insurance or membership fees
